BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26673821)

  • 1. UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation.
    Du C; Wu H; Leng RP
    Oncotarget; 2016 Jan; 7(3):2823-36. PubMed ID: 26673821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53.
    Wu H; Pomeroy SL; Ferreira M; Teider N; Mariani J; Nakayama KI; Hatakeyama S; Tron VA; Saltibus LF; Spyracopoulos L; Leng RP
    Nat Med; 2011 Mar; 17(3):347-55. PubMed ID: 21317885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of p53 level by UBE4B in breast cancer.
    Zhang Y; Lv Y; Zhang Y; Gao H
    PLoS One; 2014; 9(2):e90154. PubMed ID: 24587254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation.
    Wu H; Leng RP
    Cell Cycle; 2011 Jun; 10(12):1912-5. PubMed ID: 21558803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-1301 suppresses tumor cell migration and invasion by targeting the p53/UBE4B pathway in multiple human cancer cells.
    Wang B; Wu H; Chai C; Lewis J; Pichiorri F; Eisenstat DD; Pomeroy SL; Leng RP
    Cancer Lett; 2017 Aug; 401():20-32. PubMed ID: 28483517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
    Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
    Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
    Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
    Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.
    Pereg Y; Shkedy D; de Graaf P; Meulmeester E; Edelson-Averbukh M; Salek M; Biton S; Teunisse AF; Lehmann WD; Jochemsen AG; Shiloh Y
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5056-61. PubMed ID: 15788536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncoprotein SS18-SSX1 promotes p53 ubiquitination and degradation by enhancing HDM2 stability.
    D'Arcy P; Maruwge W; Ryan BA; Brodin B
    Mol Cancer Res; 2008 Jan; 6(1):127-38. PubMed ID: 18234968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF.
    Dias SS; Milne DM; Meek DW
    Oncogene; 2006 Oct; 25(50):6666-71. PubMed ID: 16702947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner.
    Obata M; Kominami R; Mishima Y
    Cell Signal; 2012 May; 24(5):1047-52. PubMed ID: 22245141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
    Moumen A; Masterson P; O'Connor MJ; Jackson SP
    Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage.
    Yan J; Menendez D; Yang XP; Resnick MA; Jetten AM
    J Biol Chem; 2009 Jul; 284(29):19280-9. PubMed ID: 19433585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SWIB/MDM2 motif of UBE4B activates the p53 pathway.
    Wu HH; Leng S; Abuetabh Y; Sergi C; Eisenstat DD; Leng R
    Mol Ther Nucleic Acids; 2023 Mar; 31():466-481. PubMed ID: 36865087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
    Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
    Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover.
    Dumaz N; Milne DM; Jardine LJ; Meek DW
    Biochem J; 2001 Oct; 359(Pt 2):459-64. PubMed ID: 11583595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.
    Chen H; Han L; Tsai H; Wang Z; Wu Y; Duo Y; Cao W; Chen L; Tan Z; Xu N; Huang X; Zhuang J; Huang L
    Oncotarget; 2016 Dec; 7(50):83241-83257. PubMed ID: 27829214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.